Skip to main content
Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · IEX Real-Time Price · USD
3.200
+0.050 (1.59%)
Apr 26, 2024, 4:30 PM EDT - Market closed

Repare Therapeutics Revenue

In the year 2023, Repare Therapeutics had annual revenue of $51.13M, a decrease of -61.21%. Revenue in the quarter ending December 31, 2023 was $13.05M, a -28.31% decrease year-over-year.

Revenue (ttm)
$51.13M
Revenue Growth
-61.21%
P/S Ratio
2.64
Revenue / Employee
$285,659
Employees
179
Market Cap
134.98M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202351.13M-80.70M-61.21%
Dec 31, 2022131.83M124.23M1,634.61%
Dec 31, 20217.60M7.47M5,529.63%
Dec 31, 2020135.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Electromed 51.69M
Biodesix 49.09M
Scilex Holding Company 46.74M
Augmedix 44.86M
ClearPoint Neuro 23.96M
DBV Technologies 15.73M
Syros Pharmaceuticals 9.94M
Delcath Systems 2.07M
Revenue Rankings

RPTX News

More News